Skip to main content
Fig. 3 | Systematic Reviews

Fig. 3

From: Estimating and visualising the trade-off between benefits and harms on multiple clinical outcomes in network meta-analysis

Fig. 3

\({SAWIS}_{i}\) quantity for the network of pharmacological and dietary‑supplement treatments for autism spectrum disorder. The benefit spie chart included two efficacy outcomes, changes in core symptoms for social-communication difficulties, and repetitive behaviours with weights 0.5 each, and the safety spie chart included one outcome, any adverse event

Back to article page